| 2534 |
1956: Binding to hERG channel |
1958: Direct hERG channel blockage |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2535 |
1957: hERG channel biogenesis interference |
1958: Direct hERG channel blockage |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2536 |
1957: hERG channel biogenesis interference |
1959: Induction of hERG trafficking defects |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2537 |
1958: Direct hERG channel blockage |
1960: Inhibition of Ikr |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2538 |
1959: Induction of hERG trafficking defects |
1960: Inhibition of Ikr |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2539 |
1960: Inhibition of Ikr |
1961: Prolongation of Action Potential |
Dec 13, 2021 |
Dec 13, 2021 |
None
|
| 2544 |
1954: Gut dysbiosis |
1497: Recruitment of inflammatory cells |
Dec 15, 2021 |
Dec 15, 2021 |
None
|
| 2543 |
1497: Recruitment of inflammatory cells |
1954: Gut dysbiosis |
Dec 15, 2021 |
Dec 15, 2021 |
None
|
| 2560 |
1777: Increase, Ovarian follicle breakdown |
328: Decrease, Fecundity |
Feb 4, 2022 |
Feb 4, 2022 |
None
|
| 2420 |
281: T4 in serum, Decreased |
753: Increase, Thyroid-stimulating hormone (TSH) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2421 |
737: Decreased, Uptake of inorganic iodide |
277: TH synthesis, Decreased |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2423 |
1021: Increased, T4/T3 catabolism |
281: T4 in serum, Decreased |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2425 |
1023: Increased, Thyroid-stimulating hormone (TSH) |
753: Increase, Thyroid-stimulating hormone (TSH) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2426 |
1025: Increased, Hyperplasia (follicular cells) |
741: Increase, Adenomas/carcinomas (follicular cell) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2427 |
1024: Increased, Hypertrophy and proliferation (follicular cell) |
740: Increase, Hyperplasia (follicular cells) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2406 |
1878: Decreased, Eye size |
351: Increased Mortality |
May 28, 2021 |
May 28, 2021 |
None
|
| 2428 |
295: Induction, Upregulation of glucuronyltransferase activity |
1021: Increased, T4/T3 catabolism |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2516 |
1947: Pericyte dysfunction |
1913: Endothelial cell dysfunction |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2513 |
1750: Increased inflammatory immune responses |
1934: Heart attack |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2512 |
1666: dysfunction of microcirculation |
1750: Increased inflammatory immune responses |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2511 |
1913: Endothelial cell dysfunction |
1666: dysfunction of microcirculation |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2510 |
1738: SARS-CoV-2 cell entry |
1913: Endothelial cell dysfunction |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2509 |
1948: Upregulation of ACE2 |
1738: SARS-CoV-2 cell entry |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2508 |
1535: Heart failure |
1948: Upregulation of ACE2 |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2514 |
1535: Heart failure |
1946: Altered mechanotransduction properties of pericytes |
Oct 28, 2021 |
Oct 28, 2021 |
None
|